Search

Displaying results 3611 - 3620 of 7065 in total
  1. Drug

    Tiotidine

    go.drugbank.com/drugs/DB20648
    Experimental

    Tiotidine has a monoisotopic molecular weight of 312.09 Da. … Tiotidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Tiotidine is a histamine- H2​-receptor antagonist, cimetidine derivative.

  2. Drug

    Mitratapide

    go.drugbank.com/drugs/DB20687
    Experimental

    Mitratapide has a monoisotopic molecular weight of 716.27 Da. … Mitratapide is a small molecule drug. The usage of the INN stem '-tapide' in the name indicates that Mitratapide is a microsomal triglyceride transfer protein (MTP) inhibitor.

  3. Drug

    Salfluverine

    go.drugbank.com/drugs/DB20724
    Experimental

    Salfluverine has a monoisotopic molecular weight of 281.07 Da. … Salfluverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Salfluverine is a spasmolytic with a papaverine-like action.

  4. Drug

    Susalimod

    go.drugbank.com/drugs/DB20794
    Experimental

    Susalimod has a monoisotopic molecular weight of 408.08 Da. … Susalimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Susalimod is a immunomodulator, both stimulant/suppressive and stimulant.

  5. Drug

    Demelverine

    go.drugbank.com/drugs/DB20956
    Experimental

    Demelverine has a monoisotopic molecular weight of 239.17 Da. … Demelverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Demelverine is a spasmolytic with a papaverine-like action.

  6. Drug

    Tamoxifen

    go.drugbank.com/drugs/DB00675
    ApprovedInvestigational

    [A1026] Tamoxifen was granted FDA approval on 30 December 1977.[L7799] … Tamoxifen is a non-steroidal antiestrogen used to treat estrogen receptor positive breast cancers as well as prevent the incidence of breast cancer in high risk populations.

    Categories: UGT2B7 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates with a Narrow Therapeutic IndexInternational brands: Nolvadex-D
  7. Drug

    Adapalene

    go.drugbank.com/drugs/DB00210
    ApprovedInvestigational

    On December 8th, 2008, Galderma Labs gained FDA approval for Epiduo®, a 0.1% adapalene, 2.5% BPO combination gel.[L12873] … [A193518] Differin®, produced by Galderma Labs, was first granted FDA approval on May 31st, 1996, as a 0.1% adapalene topical solution.

    Products: T3 Ada Gel 0.1%
  8. Drug

    Manganese gluconate

    go.drugbank.com/drugs/DB11141
    Approved

    Manganese gluconate is a direct ingredient in food substances as a nutrient supplement. In pharmaceutical preparations it is used as a [DB06757] supplement. … Manganese gluconate is a manganese salt of gluconic acid with the chemical formula C12H22MnO14 x 2H2O.

    Synonyms: Manganese D-gluconate
  9. Drug

    Pipotiazine

    go.drugbank.com/drugs/DB01621
    ApprovedInvestigationalWithdrawn

    However, it produces a high incidence of extra pyramidal reactions. It is used for the maintenance treatment of chronic non-agitated schizophrenic patients. … Among the different phenothiazine derivatives, it appears to be less sedating and to have a weak propensity for causing hypotension or potentiating the effects of CNS depressants and anesthetics.

    Categories: Dopamine D2 Receptor Antagonists
  10. Drug

    Lisdexamfetamine

    go.drugbank.com/drugs/DB01255
    ApprovedInvestigational

    Lisdexamfetamine is a prodrug of [dextroamphetamine], a central nervous system stimulant known as d-amphetamine,[A40246] covalently attached to the naturally occurring amino acid L-lysine. … [A2230] Lisdexamfetamine is the first chemically formulated prodrug stimulant [A40246] and was first approved by the FDA in April 2008.[A2230] It was also approved by Health Canada in February 2009.